Telehealth Software Market Report 2026

The telehealth software market size has grown rapidly in recent years. It will grow from $11.25 billion in 2025 to $13.3 billion in 2026 at a compound annual growth rate (CAGR) of 18.2%. The growth in the historic period can be attributed to increasing digitization of healthcare workflows, rising adoption of electronic prescribing systems, expansion of cloud computing in healthcare, growing need for care coordination tools, improvements in healthcare data interoperability.

The telehealth software market size is expected to see rapid growth in the next few years. It will grow to $23.56 billion in 2030 at a compound annual growth rate (CAGR) of 15.4%. The growth in the forecast period can be attributed to increasing investments in AI-driven healthcare software, rising demand for remote chronic disease management, expansion of value-based care models, growing focus on cybersecurity compliance, increasing integration of telehealth software with clinical systems. Major trends in the forecast period include increasing adoption of integrated telehealth software platforms, rising use of AI-based clinical decision support tools, growing demand for medication adherence monitoring solutions, expansion of cloud-based telehealth applications, enhanced focus on secure health data management.

The rising prevalence of chronic diseases is expected to drive the growth of the telehealth software market in the coming years. Chronic diseases are long-term conditions characterized by persistent or recurring symptoms that typically require ongoing management and treatment. Their prevalence is increasing due to factors such as aging populations, tobacco and alcohol use, and limited access to healthcare. Telehealth software supports the management of chronic diseases by providing remote access to healthcare services, enabling patients to receive regular monitoring and consultations without in-person visits. This accessibility encourages early detection, continuous care, and patient empowerment, ultimately improving outcomes for individuals with chronic conditions. For example, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over 500 million people globally were living with diabetes, with this number expected to more than double to 1.3 billion by 2050. Consequently, the growing prevalence of chronic diseases is fueling the expansion of the telehealth software market.

Key companies in the telehealth software market are emphasizing the development of advanced AI-enabled platforms that provide personalized, high-efficacy treatments and seamless remote diagnosis. For instance, in November 2025, ODDITY Tech Ltd., an Israel-based technology company, launched METHODIQ, a telehealth platform designed to modernize medical care by delivering personalized treatments through online diagnosis. Initially focusing on dermatology, the platform targets common conditions such as acne, eczema, and hyperpigmentation, aiming to bridge the gap between ineffective over-the-counter options and expensive in-person visits. Developed with dermatologists, METHODIQ integrates AI-driven skin analysis, computer-vision tracking, and a wide portfolio of prescription, OTC, and cosmetic products, including proprietary ingredients from ODDITY Labs. With over 100 tailored treatment plans and real-time clinician monitoring, METHODIQ offers a data-driven, accessible, and patient-centered approach, supported by extensive research and large-scale consumer studies.

In August 2023, Exor N.V., a Netherlands-based diversified investment company, acquired Philips for $2.8 billion. Through this acquisition, Exor aims to expand its portfolio by leveraging Philips’s expertise in telehealth software. Koninklijke Philips N.V., based in the Netherlands, provides telehealth solutions.

Major companies operating in the telehealth software market are Teladoc Health Inc, American Well Corporation, Cerner Corporation, Allscripts Healthcare LLC, Oracle Corporation, Koninklijke Philips N.V, Zoom Video Communications Inc, Zocdoc Inc, CureMD Healthcare, Vocera Communications Inc, Care Innovations LLC, GlobalMedia Group LLC, Updox LLC, Capsule Technologies Inc, Biotricity Inc, BioTelemetry, Medtronic Inc, Masimo Corporation, Aerotel Medical Systems Ltd, PatientSafe Solutions Inc.

North America was the largest region in the telehealth software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the telehealth software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the telehealth software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the telehealth software market by increasing costs associated with imported IT infrastructure, data servers, networking equipment, and specialized healthcare software components. Healthcare organizations in North America and Europe are most affected due to reliance on imported enterprise IT systems, while Asia-Pacific faces cost pressures related to cloud infrastructure expansion. These tariffs are increasing implementation expenses and slowing digital transformation initiatives. However, they are also supporting domestic software development, regional cloud service adoption, and localized technology ecosystems that enhance long-term software innovation.

The telehealth software market research report is one of a series of new reports that provides telehealth software market statistics, including telehealth software industry global market size, regional shares, competitors with a telehealth software market share, detailed telehealth software market segments, market trends and opportunities, and any further data you may need to thrive in the telehealth software industry. This telehealth software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Telehealth software refers to digital platforms and solutions that facilitate remote healthcare services and consultations. It allows healthcare clinicians to electronically prescribe medications, send prescriptions directly to pharmacies, and monitor patients’ medication adherence.

The primary components of telehealth software are software and services. Software includes digital solutions designed to support remote healthcare delivery, enabling virtual consultations, remote monitoring, and patient engagement. It can be deployed on-premises or in the cloud and is used by end-users such as healthcare providers, healthcare payers, and patients.

The telehealth software market consists of revenues earned by entities by providing services such as remote prescription services, remote patient monitoring (RPM), teleconsultations, healthcare education and training, teletherapy and behavioral health services, and data analytics and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.